Publication | Open Access
The Outcome of TGFβ Antagonism in Metastatic Breast Cancer Models <i>In Vivo</i> Reflects a Complex Balance between Tumor-Suppressive and Proprogression Activities of TGFβ
25
Citations
42
References
2019
Year
Contrary to dogma, tumor-suppressive responses to TGFβ are retained in some advanced metastatic tumors. Safe deployment of TGFβ antagonists in the clinic will require good predictive biomarkers.
| Year | Citations | |
|---|---|---|
Page 1
Page 1